YaoGeJu

Company directoryChina company filings

PKU HealthCare Corp.,Ltd.

As of 17 November 2026, for the company name PKU HealthCare Corp.,Ltd. as recorded, 6 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 49 records, across 29 drug names; since 21 August 2026, the records list Accepted: 2 applications, No longer listed under review: 1 application; the chemical-drug catalogue lists 36 active records with this name as holder; 24 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/17
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.

Drug filings

49 acceptance records as first applicant, grouped into 29 source drug names. Source data as of 2026/11/17.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Upadacitinib Sustained-release Tablets 1 records · Latest accepted 2026/09/16

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602299Generic2026/09/16PKU HealthCare Corp.,Ltd.CDE ↗
Oseltamivir Phosphate Capsules 1 records · Latest accepted 2026/09/07

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602219Generic2026/09/07PKU HealthCare Corp.,Ltd.CDE ↗
Lurasidone Hydrochloride Tablets 2 records · Latest accepted 2026/05/14

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601157Generic2026/05/14PKU HealthCare Corp.,Ltd.CDE ↗
CYHS2601156Generic2026/05/14PKU HealthCare Corp.,Ltd.CDE ↗
Moxifloxacin Hydrochloride Tablets 2 records · Latest accepted 2026/01/12

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600143Generic2026/01/12PKU HealthCare Corp.,Ltd.CDE ↗
CYHS2500495Generic2025/01/25PKU HealthCare Corp.,Ltd.CDE ↗
Paracetamol and Ibuprofen Tablets 1 records · Latest accepted 2025/12/02

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2502455Supplement2025/12/02PKU HealthCare Corp.,Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
硫酸艾沙康唑胶囊 · No verified English name 1 records · Latest accepted 2025/09/28

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503543Generic2025/09/28PKU HealthCare Corp.,Ltd.CDE ↗
Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets 3 records · Latest accepted 2025/07/15

Supplement · 1Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2501412Supplement2025/07/15PKU HealthCare Corp.,Ltd.CDE ↗
CYHS2301522Generic2023/06/03PKU HealthCare Corp.,Ltd.CDE ↗
CYHS2301521Generic2023/06/03PKU HealthCare Corp.,Ltd.CDE ↗
Olanzapine Tablets 2 records · Latest accepted 2025/07/08

Supplement · 1Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2501334Supplement2025/07/08PKU HealthCare Corp.,Ltd.CDE ↗
CYHS2101122Generic2021/05/06PKU HealthCare Corp.,Ltd.CDE ↗
Tofacitinib Citrate Extended Release tablets 1 records · Latest accepted 2025/06/07

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502027Generic2025/06/07PKU HealthCare Corp.,Ltd.CDE ↗
Rosuvastatin Calcium and Ezetimibe Tablets (I) 1 records · Latest accepted 2025/05/08

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501659Generic2025/05/08PKU HealthCare Corp.,Ltd.CDE ↗
Paliperidone Extend-release Tablets 2 records · Latest accepted 2025/02/09

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500647Generic2025/02/09PKU HealthCare Corp.,Ltd.CDE ↗
CYHS2500646Generic2025/02/09PKU HealthCare Corp.,Ltd.CDE ↗
Quetiapine Fumarate Extended-release Tablets 4 records · Latest accepted 2025/01/14

Supplement · 2Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2500094Supplement2025/01/14PKU HealthCare Corp.,Ltd.CDE ↗
CYHB2500013Supplement2025/01/03PKU HealthCare Corp.,Ltd.CDE ↗
CYHS2301283Generic2023/05/12PKU HealthCare Corp.,Ltd.CDE ↗
CYHS2301282Generic2023/05/12PKU HealthCare Corp.,Ltd.CDE ↗
Oseltamivir Phosphate For Oral Suspension 1 records · Latest accepted 2024/11/12

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401866Supplement2024/11/12PKU HealthCare Corp.,Ltd.; Shandong Lang Nuo Pharmaceutical Co., Ltd. romanizedCDE ↗
Ondansetron Hydrochloride Tablets 1 records · Latest accepted 2024/08/09

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450427Supplement2024/08/09PKU HealthCare Corp.,Ltd.CDE ↗
阿普米司特片 · No verified English name 2 records · Latest accepted 2024/07/27

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402371Generic2024/07/27PKU HealthCare Corp.,Ltd.CDE ↗
CYHS2402370Generic2024/07/27PKU HealthCare Corp.,Ltd.CDE ↗
Loratadine Tablets 2 records · Latest accepted 2024/02/28

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400308Supplement2024/02/28PKU HealthCare Corp.,Ltd.CDE ↗
CYHB2150952Supplement2021/10/28PKU HealthCare Corp.,Ltd.CDE ↗
注射用头孢唑肟钠 · No verified English name 2 records · Latest accepted 2024/01/08

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450011Supplement2024/01/08PKU HealthCare Corp.,Ltd.CDE ↗
CYHB2450010Supplement2024/01/08PKU HealthCare Corp.,Ltd.CDE ↗
Buspirone Hydrochloride Tablets 2 records · Latest accepted 2023/11/08

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350813Supplement2023/11/08PKU HealthCare Corp.,Ltd.CDE ↗
CYHB2350812Supplement2023/11/08PKU HealthCare Corp.,Ltd.CDE ↗
Vortioxetine Hydrobromide Tablets 3 records · Latest accepted 2023/07/15

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2301912Generic2023/07/15PKU HealthCare Corp.,Ltd.CDE ↗
CYHS2301911Generic2023/07/15PKU HealthCare Corp.,Ltd.CDE ↗
CYHS2301910Generic2023/07/15PKU HealthCare Corp.,Ltd.CDE ↗
Clindamycin Palmitate Hydrochloride Granules 2 records · Latest accepted 2023/07/11

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350547Supplement2023/07/11PKU HealthCare Corp.,Ltd.CDE ↗
CYHB2350546Supplement2023/07/11PKU HealthCare Corp.,Ltd.CDE ↗
Tenofovir alafenamide Fumarate Tablets 1 records · Latest accepted 2023/06/13

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2301320Supplement2023/06/13PKU HealthCare Corp.,Ltd.; Shandong Lang Nuo Pharmaceutical Co., Ltd. romanizedCDE ↗
Levocetirizine dihydrochloride Oral Solution 2 records · Latest accepted 2023/01/12

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300112Generic2023/01/12PKU HealthCare Corp.,Ltd.CDE ↗
CYHS2300111Generic2023/01/12PKU HealthCare Corp.,Ltd.CDE ↗
Palonosetron Hydrochloride Injection 1 records · Latest accepted 2022/04/18

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250216Supplement2022/04/18PKU HealthCare Corp.,Ltd.CDE ↗
Cefotaxime Sodium For Injection 2 records · Latest accepted 2022/01/12

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250030Supplement2022/01/12PKU HealthCare Corp.,Ltd.CDE ↗
CYHB2250029Supplement2022/01/12PKU HealthCare Corp.,Ltd.CDE ↗
Trimetazidine Dihydrochloride Modified Release Tablets 1 records · Latest accepted 2021/12/07

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2102255Supplement2021/12/07PKU HealthCare Corp.,Ltd.; Beijing Bai Mei Te Biopharmaceutical Co., Ltd. romanizedCDE ↗
Tandospirone Citrate Tablets 2 records · Latest accepted 2021/11/19

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2102037Generic2021/11/19PKU HealthCare Corp.,Ltd.CDE ↗
CYHS2102036Generic2021/11/19PKU HealthCare Corp.,Ltd.CDE ↗
Ornidazole Injection 2 records · Latest accepted 2021/06/28

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101346Generic2021/06/28PKU HealthCare Corp.,Ltd.CDE ↗
CYHS2101345Generic2021/06/28PKU HealthCare Corp.,Ltd.CDE ↗
Compound Sulfamethoxazole Tablets 1 records · Latest accepted 2021/01/16

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150036Supplement2021/01/16PKU HealthCare Corp.,Ltd.CDE ↗
Ambroxol Hydrochloride Injection 1 records · Latest accepted 2021/01/01

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2000956Generic2021/01/01PKU HealthCare Corp.,Ltd.CDE ↗

Changes in the last 90 days

3 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 2 applicationsNo longer listed under review: 1 application

  1. 2026/11/03No longer listed under review

    Tofacitinib Citrate Extended Release tablets

    CYHS2502027

    Fact date: 2026/11/03 · Date added to this site: 2026/11/03

    Accepted: 2025/06/07

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗
  2. 2026/09/16Accepted

    Upadacitinib Sustained-release Tablets

    CYHS2602299

    Fact date: 2026/09/16 · Date added to this site: 2026/10/22

    View source ↗
  3. 2026/09/07Accepted

    Oseltamivir Phosphate Capsules

    CYHS2602219

    Fact date: 2026/09/07 · Date added to this site: 2026/10/22

    View source ↗

Under review

6 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Upadacitinib Sustained-release Tablets CYHS2602299Generic2026/09/16PKU HealthCare Corp.,Ltd.CDE ↗
Oseltamivir Phosphate Capsules CYHS2602219Generic2026/09/07PKU HealthCare Corp.,Ltd.CDE ↗
Lurasidone Hydrochloride Tablets CYHS2601157Generic2026/05/14PKU HealthCare Corp.,Ltd.CDE ↗
Lurasidone Hydrochloride Tablets CYHS2601156Generic2026/05/14PKU HealthCare Corp.,Ltd.CDE ↗
Moxifloxacin Hydrochloride Tablets CYHS2600143Generic2026/01/12PKU HealthCare Corp.,Ltd.CDE ↗
硫酸艾沙康唑胶囊 · No verified English name CYHS2503543Generic2025/09/28PKU HealthCare Corp.,Ltd.CDE ↗

Catalogue holder records

36 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Paliperidone Extend-release TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202648232026/06/17Generic approved under the new chemical-drug registration classificationCDE ↗
Paliperidone Extend-release TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202648222026/06/17Generic approved under the new chemical-drug registration classificationCDE ↗
Quetiapine Fumarate Extended-release TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202582702025/12/05Generic approved under the new chemical-drug registration classificationCDE ↗
Olanzapine TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202582182025/09/28Generic approved under the new chemical-drug registration classificationCDE ↗
阿普米司特片 · No verified English namePKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202555282025/09/16Generic approved under the new chemical-drug registration classificationCDE ↗
阿普米司特片 · No verified English namePKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202555272025/09/16Generic approved under the new chemical-drug registration classificationCDE ↗
Ondansetron Hydrochloride TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H109701552025/04/11Drug that passed quality-and-efficacy consistency evaluationCDE ↗
注射用头孢唑肟钠 · No verified English namePKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H200900722025/03/25Drug that passed quality-and-efficacy consistency evaluationCDE ↗
注射用头孢唑肟钠 · No verified English namePKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H200900712025/03/25Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Buspirone Hydrochloride TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H199903022024/12/16Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Buspirone Hydrochloride TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202473182024/12/16Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Vortioxetine Hydrobromide TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202493562024/11/15Generic approved under the new chemical-drug registration classificationCDE ↗
Vortioxetine Hydrobromide TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202493582024/11/15Generic approved under the new chemical-drug registration classificationCDE ↗
Quetiapine Fumarate Extended-release TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202493522024/11/15Generic approved under the new chemical-drug registration classificationCDE ↗
Vortioxetine Hydrobromide TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202493572024/11/15Generic approved under the new chemical-drug registration classificationCDE ↗
Paroxetine Hydrochloride Enteric-Coated Sustained-Release TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202491812024/10/22Generic approved under the new chemical-drug registration classificationCDE ↗
Palonosetron Hydrochloride InjectionPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H201301082023/09/11Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Tandospirone Citrate TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202333432023/03/24Generic approved under the new chemical-drug registration classificationCDE ↗
Tandospirone Citrate TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202333422023/03/24Generic approved under the new chemical-drug registration classificationCDE ↗
Ornidazole InjectionPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202237702022/10/25Generic approved under the new chemical-drug registration classificationCDE ↗
Ornidazole InjectionPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202237692022/10/25Generic approved under the new chemical-drug registration classificationCDE ↗
Loratadine TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H200407842022/09/29Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Olanzapine TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202235162022/07/07Generic approved under the new chemical-drug registration classificationCDE ↗
Ambroxol Hydrochloride InjectionPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202232572022/04/27Generic approved under the new chemical-drug registration classificationCDE ↗
Compound Sulfamethoxazole TabletsPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H500205572022/03/30Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Meropenem for InjectionPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H200932642021/10/11Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Meropenem for InjectionPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H200932632021/10/11Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Celecoxib CapsulesPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202137172021/09/13Generic approved under the new chemical-drug registration classificationCDE ↗
Cefminox Sodium for InjectionPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H200562982021/09/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefminox Sodium for InjectionPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H200562972021/09/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ceftriaxone Sodium for InjectionPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H109100332021/04/21Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ceftriaxone Sodium for InjectionPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H500202762021/04/21Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ceftriaxone Sodium for InjectionPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H500202752021/04/21Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefotaxime Sodium For InjectionPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H500218002023/01/31Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefotaxime Sodium For InjectionPKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H500204912023/01/31Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Rosuvastatin Calcium and Ezetimibe Tablets (I)PKU HealthCare Corp.,Ltd.PKU HealthCare Corp.,Ltd.国药准字H202662042026/10/13Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

24 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.

NameCompany / applicantRegistration numberStatusSource update dateView source
盐酸鲁拉西酮 · No verified English namePKU HealthCare Corp.,Ltd.Y20250000614I2025/06/24CDE ↗
枸橼酸托法替布 · No verified English namePKU HealthCare Corp.,Ltd.Y20240001104A2026/04/29CDE ↗
帕利哌酮 · No verified English namePKU HealthCare Corp.,Ltd.Y20240000871A2026/09/21CDE ↗
氢溴酸伏硫西汀 · No verified English namePKU HealthCare Corp.,Ltd.Y20230000027A2024/07/17CDE ↗
萘丁美酮 · No verified English namePKU HealthCare Corp.,Ltd.Y20180001801A2024/02/05CDE ↗
格列美脲 · No verified English namePKU HealthCare Corp.,Ltd.Y20190007785A2025/04/02CDE ↗
米力农 · No verified English namePKU HealthCare Corp.,Ltd.Y20190007401A2023/12/23CDE ↗
盐酸帕洛诺司琼 · No verified English namePKU HealthCare Corp.,Ltd.Y20190007327A2023/08/29CDE ↗
奥氮平 · No verified English namePKU HealthCare Corp.,Ltd.Y20190006557A2026/03/06CDE ↗
枸橼酸坦度螺酮 · No verified English namePKU HealthCare Corp.,Ltd.Y20190006503A2026/03/06CDE ↗
卡维地洛 · No verified English namePKU HealthCare Corp.,Ltd.Y20190005364A2025/08/08CDE ↗
盐酸丁螺环酮 · No verified English namePKU HealthCare Corp.,Ltd.Y20190002254A2025/04/02CDE ↗
盐酸格拉司琼 · No verified English namePKU HealthCare Corp.,Ltd.Y20190002252A2025/04/02CDE ↗
盐酸昂丹司琼 · No verified English namePKU HealthCare Corp.,Ltd.Y20190002237A2025/09/01CDE ↗
盐酸克林霉素棕榈酸酯 · No verified English namePKU HealthCare Corp.,Ltd.Y20190001954A2025/04/02CDE ↗
右旋酮洛芬 · No verified English namePKU HealthCare Corp.,Ltd.Y20190001332A2024/02/05CDE ↗
曲昔派特 · No verified English namePKU HealthCare Corp.,Ltd.Y20170002197A2024/02/05CDE ↗
埃索美拉唑钠 · No verified English namePKU HealthCare Corp.,Ltd.Y20170001691I—CDE ↗
盐酸莫西沙星 · No verified English namePKU HealthCare Corp.,Ltd.Y20170001426A2024/08/27CDE ↗
阿戈美拉汀 · No verified English namePKU HealthCare Corp.,Ltd.Y20170000370I—CDE ↗
酮亮氨酸钙 · No verified English namePKU HealthCare Corp.,Ltd.Y20170000272I—CDE ↗
酮缬氨酸钙 · No verified English namePKU HealthCare Corp.,Ltd.Y20170000271I—CDE ↗
酮苯丙氨酸钙 · No verified English namePKU HealthCare Corp.,Ltd.Y20170000270I—CDE ↗
消旋酮异亮氨酸钙 · No verified English namePKU HealthCare Corp.,Ltd.Y20170000269I—CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/17
Chemical-drug catalogue
Last successful update: 2026/11/17
API registrations
Last successful update: 2026/11/17
NMPA drug delivery notices
Last successful update: 2026/11/17

Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.